On October 28, 2021, Partner Courtney Brinckerhoff will present, “Patenting Issues Facing Innovators in the Life Sciences Including Sections 101, 112 and in Connection with COVID-19 Vaccines,” during the American Intellectual Property Law Association (AIPLA) 2021 Annual Meeting, being held October 28-30, 2021.
Additional programs during the patent prosecution track include:
- An Exemplary Study: Comparing Europe and US Guidance Examples and Recent Developments in Patenting Computer-Implemented Inventions
Mike Jennings, AA Thornton, London, UK - Following the Example: Effective Claim Drafting for AI/ML and Computer Simulation in Europe and the US
Michael W. Piper, Conley Rose, Plano, TX - Current Patenting Issues in Europe Facing Life Sciences/Biotech Innovators, and Effective Claim Drafting Strategies to Avoid Pitfalls
Andrew Bentham, JA Kemp, London, United Kingdom
The AIPLA Annual Meeting is a three-day event that brings together over 1,000 intellectual property practitioners to network and discuss issues relevant to their practice.
For more information please visit the program website.
To register to attend the event in person, click here and to attend virtually, click here.
People
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.